The Public Health Commission has approved the vaccination against Monkeypox. And it has decided that “taking into account the limited availability of doses” it will prioritize those with a high risk of severity or exposure. “Pre-exposure vaccination is not recommended at this time, although it could be recommended later depending on the evolution of the outbreak and the availability of vaccines,” the Ministry of Health has indicated.
The Commission in which the ministry and the Autonomous Communities are represented met in person this Thursday to analyze the experts’ proposals on how to address the growing number of cases of this infection, after the first 200 vials of the vaccine.
“There are approved antivirals and vaccines for monkeypox, but their supply is limited,” the WHO explained this week. That is why a “coordination mechanism for the distribution of supplies based on public health needs and equity” is being developed. The UN agency does not recommend mass vaccination against monkeypox. In the few places where vaccines are available, they are being used to protect those who may be exposed, such as health workers and laboratory personnel.
“Some countries may consider post-exposure vaccination, ideally within four days, for higher-risk close contacts, such as sexual partners, family members living in the same household, and health workers,” explained this Wednesday the director of the Organization, Tedros Adhanom Gebreyesus.
That seems to be the option that Spain has opted for, at least until the purchases agreed through the EU suppose a greater availability of doses of the vaccine. In addition to specific vaccines, those designed against smallpox, a related and more dangerous virus that the world eradicated in 1980, are also effective.